| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/12/1999 | US5858677 Protein D--an IgD-binding protein of haemophilus influenzae |
| 01/12/1999 | US5858674 Screening assays to identify agents that modulate cisplatin resistance |
| 01/12/1999 | US5858670 Screening randomly synthesized oligopeptide- or oligonucleotide-solid phase libraries with acceptor molecules (e.g. antibodies), isolating solid phase support/oligomer bound to molecule, sequencing oligomer |
| 01/12/1999 | US5858647 Detecting binding of purified or isolated antigen of hiv-1 subtype o virus to antibodies present in biological sample, comparing to control; diagnosis of infection, aids, and aids related complex; kits |
| 01/12/1999 | US5858646 Modified HIV-pol polypeptide having immunological activity for use as diagnostic reagent |
| 01/12/1999 | US5858378 Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/12/1999 | US5858375 Pharmaceutical compositions containing D2 O |
| 01/12/1999 | US5858373 Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
| 01/12/1999 | US5858369 Anti-acids secretory recombinant BCG vaccine |
| 01/12/1999 | US5858368 Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein |
| 01/12/1999 | US5858366 Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding |
| 01/12/1999 | US5858365 Administering butyric acid and an amino acid, heptafluorobutyric acid, 3-chloropropionic acid, beta-chloro-l-alanine hydrochloride and isobutyramide for ulcers |
| 01/12/1999 | US5858364 Orally or enterally administering myelin |
| 01/12/1999 | US5858363 Target specific antibody-superantigen conjugates and their preparation |
| 01/12/1999 | US5858361 Monoclonal anti-idiotypic anti-CA125 antibodies and pharmaceutical compositions containing them |
| 01/12/1999 | US5858360 Mediate embryo-endometrium adhesion; anti-trophinin antibodies for inhibition; trophinin-assisting proteins tastin, bystin, lastin for increasing binding; endometrial adenocarcinoma |
| 01/12/1999 | CA1340312C Methods for improved targeting of antibody, antibody fragments, hormonesand other targeting agents and conjugates thereof |
| 01/10/1999 | CA2237138A1 25-hydroxyvitamin d3-1.alpha.-hydroxylase and dna encoding the hydroxylase |
| 01/10/1999 | CA2236493A1 Mura |
| 01/10/1999 | CA2236485A1 Novel 1spa |
| 01/10/1999 | CA2209815A1 Vaccine method using osmotic pump |
| 01/09/1999 | CA2205881A1 Tcr scfv and biological applications thereof |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/08/1999 | CA2236468A1 Novel use |
| 01/08/1999 | CA2229464A1 Hfizg53 |
| 01/07/1999 | WO1999000511A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | WO1999000510A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 01/07/1999 | WO1999000507A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | WO1999000490A2 Attenuated human immunodeficiency virus vaccine |
| 01/07/1999 | WO1999000422A1 Novel family of pheromone receptors |
| 01/07/1999 | WO1999000421A1 Site-directed chemotherapy of metastases |
| 01/07/1999 | WO1999000420A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | WO1999000414A1 Chlamydia trachomatis specific peptides and their use in diagnostic assays |
| 01/07/1999 | WO1999000413A1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 01/07/1999 | WO1999000410A2 Human extracellular matrix proteins |
| 01/07/1999 | WO1999000142A1 Method for inducing a systemic immune response to a hepatitis or hiv antigen |
| 01/07/1999 | WO1999000141A1 Use of bromelain in the manufacture of a medicament for enhancement of intestinal permeability |
| 01/07/1999 | WO1999000137A2 Induction of an activated myeloid dendritic cell phenotype |
| 01/07/1999 | WO1999000136A1 Control of acidic gut syndrome |
| 01/07/1999 | WO1999000010A2 TRANSGENIC ANIMALS EXPRESSING HUMAN Fc RECEPTORS |
| 01/07/1999 | WO1998054213A3 Neurotrophic factor receptors |
| 01/07/1999 | WO1998045408A3 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 01/07/1999 | WO1998044094A3 Helicobacter aliphatic amidase polypeptides, dna sequences encoding those polypeptides and uses thereof |
| 01/07/1999 | WO1998042740A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/07/1999 | WO1998040049A3 Specific magnetosome, method for the production and use thereof |
| 01/07/1999 | WO1998039463A3 Lentivirus based vector and vector system |
| 01/07/1999 | WO1998039027A3 Sialyl lewis antigens as targets for immunotherapy |
| 01/07/1999 | WO1998028333A3 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889130A2 GidB polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889128A2 midA1 polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889122A2 Inhibition of DNA Methyltransferase |
| 01/07/1999 | EP0889120A1 A micro-organism having reduced adaption to a particular environment |
| 01/07/1999 | EP0889054A2 Antibody 67D2 against CD164 |
| 01/07/1999 | EP0889052A2 Immunoreactive peptides from Epstein-Barr virus |
| 01/07/1999 | EP0888778A1 Colon selective drug delivery system and compositions comprising said system |
| 01/07/1999 | EP0888777A2 Recombinant bovine herpesvirus type 1 polyptpetides and vaccines |
| 01/07/1999 | EP0888541A1 Cryptic peptides and method for their identification |
| 01/07/1999 | EP0888457A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 01/07/1999 | EP0888456A2 Prostate specific antigen oligo-epitope peptide |
| 01/07/1999 | EP0888453A1 Clostridium perfringens vaccines |
| 01/07/1999 | EP0888385A2 Uses of gdnf and gdnf receptor |
| 01/07/1999 | EP0888381A1 Targeted therapeutic or diagnostic agents and methods of making and using same |
| 01/07/1999 | EP0888377A1 MURINE $g(a)(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 01/07/1999 | EP0888375A1 A novel disintegrin metalloprotease and methods of use |
| 01/07/1999 | EP0888126A1 Anti-idiotypic antibody vaccines |
| 01/07/1999 | EP0888125A1 Glycosylated humanized b-cell specific antibodies |
| 01/07/1999 | EP0888124A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 01/07/1999 | EP0888120A1 Hla binding peptides and their uses |
| 01/07/1999 | EP0888053A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 01/07/1999 | EP0888046A1 Method of protein production using mitochondrial translation system |
| 01/07/1999 | EP0651818B1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 01/07/1999 | EP0646015B1 Contraceptive vaccine |
| 01/07/1999 | DE19728834A1 Eisenreduktase Ferric reductase |
| 01/07/1999 | CA2665707A1 Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum |
| 01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | CA2295318A1 Human extracellular matrix proteins |
| 01/07/1999 | CA2295315A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | CA2295311A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | CA2295229A1 Induction of an activated myeloid dendritic cell phenotype |
| 01/07/1999 | CA2294904A1 Control of acidic gut syndrome |
| 01/07/1999 | CA2294604A1 Transgenic animals expressing human fc receptors |
| 01/07/1999 | CA2294473A1 Novel family of pheromone receptors |
| 01/07/1999 | CA2294131A1 Site-directed chemotherapy of metastases |
| 01/06/1999 | CN1204344A Transferrin receptor protein of Moraxella |
| 01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
| 01/06/1999 | CN1203921A Membrane protein polypeptide having pre-B cell growth-supporting ability and gene thereof |
| 01/06/1999 | CN1203819A Prevention and treatment of Enterohemorrhagic Escherichia coli (EHEC) infection |
| 01/06/1999 | CN1203807A Medicine for curing recurrent stomatocace and Behcet's syndrome |
| 01/05/1999 | US5856457 To obtain dna encoding pf4a receptors, and to express them in host cells. |
| 01/05/1999 | US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor. |
| 01/05/1999 | US5856447 Vaccine against lyme disease |
| 01/05/1999 | US5856446 Method of treating rheumatoid arthritis with low dose type II collagen |